Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'secondary prevention' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 700 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Glomsrod, B; Lonn, JH; Soukup, MG; Bo, K; Larsen, S
      "Active back school", prophylactic management for low back pain: Three-year follow-up of a randomized, controlled trial

      JOURNAL OF REHABILITATION MEDICINE
    2. Herrington, DM
      Effects of oestrogen on cardiovascular events in postmenopausal women

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    3. von Schacky, C
      Dietary omega-3 fatty acids and human growth factor and cytokine gene expression

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    4. Marchioli, R
      Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione Trial

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    5. Gozzoli, V; Palmer, AJ; Brandt, A; Spinas, GA
      Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting

      SWISS MEDICAL WEEKLY
    6. Nass, CM; Allen, JK; Jermyn, RM; Fleisher, LA
      Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease

      VASCULAR MEDICINE
    7. Haq, IU; Ramsay, LE; Wallis, EJ; Isles, CG; Ritchie, LD; Jackson, PR
      Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey

      HEART
    8. McHugh, F; Lindsay, GM; Hanlon, P; Hutton, I; Brown, MR; Morrison, C; Wheatley, DJ
      Nurse led shared care for patients on the waiting list for coronary arterybypass surgery: a randomised controlled trial

      HEART
    9. Best, JD; Jenkins, AJ
      Novel agents for managing dyslipidaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Latini, R; Masson, S; Bertini, R; Maggioni, AP; Ghezzi, P; Calvillo, L
      Cardiac protection by pharmacological modulation of inflammation

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Robins, SJ
      PPAR alpha ligands and clinical trials: cardiovascular risk reduction withfibrates

      JOURNAL OF CARDIOVASCULAR RISK
    12. Stagmo, M; Westin, L; Carlsson, R; Israelsson, B
      Long-term effects on cholesterol levels and the utilization of lipid-lowering drugs of a hospital-based programme for secondary prevention of coronary artery disease

      JOURNAL OF CARDIOVASCULAR RISK
    13. Skof, E; Span, M; Keber, I
      Secondary prevention in patients several years after myocardial infarction: comparison of an outpatient and an inpatient rehabilitation programme

      JOURNAL OF CARDIOVASCULAR RISK
    14. Hedback, B; Perk, J; Hornblad, M; Ohlsson, U
      Cardiac rehabilitation after coronary artery bypass surgery: 10-year results on mortality, morbidity and readmissions to hospital

      JOURNAL OF CARDIOVASCULAR RISK
    15. Kahan, T; Wandell, P
      Risk factors in established coronary heart disease: evaluation of a secondary prevention programme

      JOURNAL OF CARDIOVASCULAR RISK
    16. Hallman, T; Burell, G; Setterlind, S; Oden, A; Lisspers, J
      Psychosocial risk factors for coronary heart disease, their importance compared with other risk factors and gender differences in sensitivity

      JOURNAL OF CARDIOVASCULAR RISK
    17. Franzosi, MG; Brunetti, M; Marchioli, R; Marfisi, RM; Tognoni, G; Valagussa, F
      Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction - Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial

      PHARMACOECONOMICS
    18. Bhana, N; McClellan, KJ
      Indobufen - An updated review of its use in the management of atherothrombosis

      DRUGS & AGING
    19. Meredith, KL; Jeffe, DB; Mundy, LM; Fraser, VJ
      Sources influencing patients in their HIV medication decisions

      HEALTH EDUCATION & BEHAVIOR
    20. Vogel, R; Schaefer, E
      Should all patients with cardiovascular disease receive statin therapy?

      AMERICAN JOURNAL OF MANAGED CARE
    21. Sanoski, CA
      Part 1 of 2 - Update on dyslipidemia management: Emerging CHD risk factors, new evidence and strategies

      FORMULARY
    22. O'Connor, S; Taylor, C; Campbell, LA; Epstein, S; Libby, P
      Potential infectious etiologies of atherosclerosis: A multifactorial perspective

      EMERGING INFECTIOUS DISEASES
    23. Aalto-Setala, K; Laitinen, K; Erkkila, L; Leinonen, M; Jauhiainen, M; Ehnholm, C; Tamminen, M; Puolakkainen, M; Penttila, I; Saikku, P
      Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    24. Saucan, L; Brinton, EA
      Lp A-I and niacin - New views of an antiatherogenic duo

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    25. Syrbe, G; Redlich, H; Weidlich, B; Ludwig, J; Kopitzsch, S; Gockeritz, A; Herzog, K
      Individual dosing of ASA prophylaxis by controlling platelet aggregation

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    26. Seeger, H; Wallwiener, D; Mueck, AO
      Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells

      MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
    27. Tamis-Holland, JE; James, JH
      Con: Postmenopausal hormone replacement therapy does not improve outcome in women undergoing coronary artery bypass graft surgery

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    28. Zlaket-Matta, G; Vela, BS; Brinton, EA
      The clinical relevance and management of high-density lipoprotein deficiency

      ENDOCRINOLOGIST
    29. Rubin, D; Lane, W; Ludwig, S
      Child abuse prevention

      CURRENT OPINION IN PEDIATRICS
    30. Hankey, GJ
      Current oral antiplatelet agents to prevent atherothrombosis

      CEREBROVASCULAR DISEASES
    31. Easton, JD
      Future perspectives for optimizing oral antiplatelet therapy

      CEREBROVASCULAR DISEASES
    32. Algra, A
      A benefit/risk analysis of the prevention of brain ischaemia with anticoagulant drugs: When, how and whom to treat?

      CEREBROVASCULAR DISEASES
    33. Jones, BT; Corbin, W; Fromme, K
      A review of expectancy theory and alcohol consumption

      ADDICTION
    34. Seddon, ME; Marshall, MN; Campbell, SM; Roland, MO
      Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand

      QUALITY IN HEALTH CARE
    35. Wright, FL; Wiles, RA; Moher, M
      Patients' and practice nurses' perceptions of secondary preventive care for established ischaemic heart disease: a qualitative study

      JOURNAL OF CLINICAL NURSING
    36. Adami, HO; Day, NE; Trichopoulos, D; Willett, WC
      Primary and secondary prevention in the reduction of cancer morbidity and mortality

      EUROPEAN JOURNAL OF CANCER
    37. Betteridge, DJ
      Lipid-lowering trials in diabetes

      CURRENT OPINION IN LIPIDOLOGY
    38. Guzic-Salobir, B; Keber, I; Seljeflot, I; Arnesen, H; Vrabic, L
      Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women

      JOURNAL OF INTERNAL MEDICINE
    39. Hooper, L
      Dietetic guidelines: diet in secondary prevention of cardiovascular disease

      JOURNAL OF HUMAN NUTRITION AND DIETETICS
    40. Hooper, L
      Survey of UK dietetic departments: diet in secondary prevention of myocardial infarction

      JOURNAL OF HUMAN NUTRITION AND DIETETICS
    41. Nair, GV; Davis, CJ; McKenzie, ME; Lowry, DR; Serebruany, VL
      Aspirin in patients with coronary artery disease: Is it simply irresistible?

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    42. van Klaveren, RJ; Habbema, JDF; Pedersen, JH; de Koning, HJ; Oudkerk, M; Hoogsteden, HC
      Lung cancer screening by low-dose spiral computed tomography

      EUROPEAN RESPIRATORY JOURNAL
    43. Cuijpers, P; van Lammeren, P
      Secondary prevention of depressive symptoms in elderly inhabitants of residential homes

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    44. Oliveria, SA; Christos, PJ; Marghoob, AA; Halpern, AC
      Skin cancer screening and prevention in the primary care setting - National Ambulatory Medical Care Survey 1997

      JOURNAL OF GENERAL INTERNAL MEDICINE
    45. Smieja, M; Cronin, L; Levine, M; Goldsmith, CH; Yusuf, S; Mahony, JB
      Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease

      CANADIAN JOURNAL OF CARDIOLOGY
    46. Baillargeon, JP; Lepage, S; Larrivee, L; Roy, MA; Landry, S; Maheux, P
      Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: Evaluation of a nurse-oriented management approach

      CANADIAN JOURNAL OF CARDIOLOGY
    47. Leys, D
      Treatment for cerebral ischemia

      PRESSE MEDICALE
    48. Younis, N; Burnham, P; Patwala, A; Weston, PJ; Vora, JP
      Beta blocker prescribing differences in patients with and without diabetesfollowing a first myocardial infarction

      DIABETIC MEDICINE
    49. Wiles, R; Kinmonth, AL
      Patients' understandings of heart attack: implications for prevention of recurrence

      PATIENT EDUCATION AND COUNSELING
    50. Thiefin, G
      Digestive toxicity of low-dose aspirin: an underestimated and unresolved problem

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    51. Ceballos, C; Ribes, C; Amado, JA; de Mier, I; de Rozas, LS; Berrazueta, JR
      Venous endothelial function in postmenopausal women after six months of tibolone therapy

      MATURITAS
    52. Arensman, E; Townsend, E; Hawton, K; Bremner, S; Feldman, E; Goldney, R; Gunnell, D; Hazell, P; Van Heeringen, K; House, A; Owens, D; Sakinofsky, I; Traskman-Bendz, L
      Psychosocial and pharmacological treatment of patients following deliberate self-harm: The methodological issues involved in evaluating effectiveness

      SUICIDE AND LIFE-THREATENING BEHAVIOR
    53. Linton, SJ; van Tulder, MW
      Preventive interventions for back and neck pain problems - What is the evidence?

      SPINE
    54. van Tulder, MW; Ostelo, R; Vlaeyen, JWS; Linton, SJ; Morley, SJ; Assendelft, WJJ
      Behavioral treatment for chronic low back pain - A systematic review within the framework of the Cochrane Back Review Group

      SPINE
    55. Bousser, MG
      Antithrombotic strategy in stroke

      THROMBOSIS AND HAEMOSTASIS
    56. Gorter, JW; Oostenbrink, JB; Tangelder, MJD
      Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease

      THROMBOSIS AND HAEMOSTASIS
    57. Koski-Jannes, A; Cunningham, J
      Interest in different forms of self-help in a general population sample ofdrinkers

      ADDICTIVE BEHAVIORS
    58. Fritz, JM; George, SZ; Delitto, A
      The role of fear-avoidance beliefs in acute low back pain: relationships with current and future disability and work status

      PAIN
    59. Shaw, WS; Feuerstein, M; Haufler, AJ; Berkowitz, SM; Lopez, MS
      Working with low back pain: problem-solving orientation and function

      PAIN
    60. van den Hout, JHC; Vlaeyen, JWS; Houben, RMA; Soeters, APM; Peters, ML
      The effects of failure feedback and pain-related fear on pain report, paintolerance, and pain avoidance in chronic low back pain patients

      PAIN
    61. Castroseiros, EF; Garcia, JM; Beiras, AC
      Analysis of the appropriate use of beta-blockers post-infarction

      REVISTA ESPANOLA DE CARDIOLOGIA
    62. Illingworth, RD; Crouse, JR; Hunninghake, DB; Davidson, MH; Escobar, ID; Stalenhoef, AFH; Paragh, G; Ma, PTS; Liu, M; Melino, MR; O'Grady, L; Mercuri, M; Mitchel, YB
      A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial

      CURRENT MEDICAL RESEARCH AND OPINION
    63. Baessler, A; Fischer, M; Hengstenberg, C; Holmer, S; Hubauer, U; Huf, V; Mell, S; Klein, G; Riegger, G; Schunkert, H
      In-hospital cardiac rehabilitation improves the implementation of secondary prevention in patients with coronary disease

      ZEITSCHRIFT FUR KARDIOLOGIE
    64. Wienbergen, H; Schiele, R; Gitt, AK; Schneider, S; Heer, T; Gohlke, H; Gottwik, M; Thiele, M; Thiele, R; Keysser, M; Horsch, A; Weizel, A; Senges, J
      Actual use of statins at hospital discharge after acute myocardial infarction

      ZEITSCHRIFT FUR KARDIOLOGIE
    65. Fischer, M; Bassler, A; Hengstenberg, C; Holmer, S; Mayer, B; Lowel, H; Riegger, G; Klein, G; Schunkert, H
      Inappropriate implementation of guideline-recommended use of ACE inhibitors after acute myocardial infarction in patients with left ventricular dysfunction

      ZEITSCHRIFT FUR KARDIOLOGIE
    66. Baessler, A; Hengstenberg, C; Holmer, S; Fischer, M; Mayer, B; Klein, G; Riegger, G; Schunkert, H
      Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile: a case-control study in pairs of siblings with myocardial infarction

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    67. Niemeijer-Kanters, SDJM; Banga, JD; Erkelens, DW
      Lipid-lowering therapy in diabetes mellitus

      NETHERLANDS JOURNAL OF MEDICINE
    68. Ayanian, JZ; Quinn, TJ
      Quality of care for coronary heart disease in two countries

      HEALTH AFFAIRS
    69. Olson, KL; Bungard, TJ; Tsuyuki, RT
      Cholesterol risk management: A systematic examination of the gap from evidence to practice

      PHARMACOTHERAPY
    70. Simpson, SH; Johnson, JA; Tsuyuki, RT
      Economic impact of community pharmacist intervention in cholesterol risk management: An evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists

      PHARMACOTHERAPY
    71. Feuerstein, M; Berkowitz, SM; Haufler, AJ; Lopez, MS; Huang, GD
      Working with low back pain: workplace and individual psychosocial determinants of limited duty and lost time

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    72. Krause, N; Dasinger, LK; Deegan, LJ; Rudolph, L; Brand, RJ
      Psychosocial job factors and return-to-work after compensated low back injury: A disability phase-specific analysis

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    73. Forrester, JS
      Triglycerides: risk factor or fellow traveler?

      CURRENT OPINION IN CARDIOLOGY
    74. Gandjour, A; Lauterbach, KW
      A method for assessing the cost-effectiveness and the break-even point of clinical practice guidelines

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    75. Luepker, RV
      Cholesterol reduction: What can we afford?

      EUROPEAN HEART JOURNAL
    76. van Hout, BA; Simoons, ML
      Cost-effectiveness of HMG coenzyme reductase inhibitors - Whom to treat?

      EUROPEAN HEART JOURNAL
    77. Kotseva, K; Wood, D; De Backer, G; De Bacquer, D; Pyorala, K; Keil, U
      Lifestyle and risk factor management and use of drug therapies in coronarypatients from 15 countries - Principal results from EUROASPIRE II Euro Heart Survey Programme

      EUROPEAN HEART JOURNAL
    78. Real, JT; Chaves, FJ; Martinez-Uso, I; Garcia-Garcia, AB; Ascaso, JF; Carmena, R
      Importance of HDL cholesterol levels and the total/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia

      EUROPEAN HEART JOURNAL
    79. Willich, SN; Muller-Nordhorn, J; Kulig, M; Binting, S; Gohlke, H; Hahmann, H; Bestehorn, K; Krobot, K; Voller, H
      Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease - A prospective cohort study

      EUROPEAN HEART JOURNAL
    80. Marchioli, R; Avanzini, F; Barzi, F; Chieffo, C; Di Castelnuovo, A; Franzosi, MG; Geraci, E; Maggioni, AP; Marfisi, RM; Mininni, N; Nicolosi, GL; Santini, M; Schweiger, C; Tavazzi, L; Tognoni, G; Valagussa, F
      Assessment of absolute risk of death after myocardial infarction by use ofmultiple-risk-factor assessment equations - GISSI-Prevenzione mortality risk chart

      EUROPEAN HEART JOURNAL
    81. Baessler, A; Hengstenberg, C; Holmer, S; Fischer, M; Mayer, A; Hubauer, U; Klein, G; Riegger, G; Schunkert, H
      Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile - A case-control study in pairs of siblings with myocardial infarction

      EUROPEAN HEART JOURNAL
    82. Ballantyne, CM
      Treating mixed dyslipidemias: Why and how

      CLINICAL CARDIOLOGY
    83. Grover, SA; Coupal, L; Zowall, H; Alexander, CM; Weiss, TW; Gomes, DRJ
      How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

      DIABETES CARE
    84. MacMahon, S; Neal, B; Tzourio, C; Rodgers, A; Woodward, M; Curler, J; Anderson, C; Chalmers, J; Ohkubo, T
      Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

      LANCET
    85. Kotseva, K; Wood, D; De Backer, G; De Bacquer, D; Pyorala, K; Keil, U; Sans, S; Ambrosio, GB; Amouyel, P; Cokkinos, D; Deckers, JW; Erhardt, L; Graham, I; Gutzwiller, F; Keber, I; Keil, U; Lehto, S; Ostor, E; Pajak, A; Sans, S; Simon, J; Turk, J; Wood, D; Wood, DA; Schofield, B; Bowker, T; Ingham, J; McLennan, N; Kotseva, K; Gollapalli, M; Valay, R; De Backer, G; De Bacquer, D; James, D; Mackness, M; Simon, J; Linhartova, K; Hafman, P; Mayer, O; Rosolova, H; Bocek, P; Hrncarek, M; Lupinek, P; Marek, T; Plaskova, M; Skodova, Z; Cifkova, R; Lehto, S; Lehto, R; Kemppainen, A; Koukkunen, H; Luukkonen, J; Puhakka, M; Karkkainen, K; Savolainen, K; Amouyel, P; Montaye, M; Lemaire, B; Danet, S; Domanievicz, R; Lenoir, M; Beauchant, S; Dusart, A; Bonte, F; Fievet, N; Poissonnier, L; Ledoux, P; Marecaux, N; Steclebout, C; Keil, U; Liese, A; Broxtermann, U; Heimbach, M; Heidrich, J; Kalic, M; Breithardt, G; Enbergs, A; Kerber, S; Scheld, H; Roeder, N; Kleine-Katthofer, P; Assmann, G; Ostor, E; Borbas, S; Podmaniczky, M; Ruzsanyi, T; Janosi, A; Belatiny-Kenez, A; Bradak, A; Adam, Z; Barczy, G; Birtalan, K; Gallai, I; Ambrosio, GB; Leprotti, C; Zardini, P; Rossi, L; Gallo, A; Tavella, D; Stritoni, P; Pedrocco, A; Perissinotto, F; Vanuzzo, D; Pilotto, L; Deckers, JW; Post, F; Jansen, C; Veerhoek, M; Boer, A; Stockx, E; van de Berg, R; Remme, WJ; van Vliet, R; Vos, J; van der Knaap, M; Turk, J; Keber, I; Marn, K; Salapura, V; Skof, E; Span, E; Sans, S; Paluzie, G; Perez, I; Puig, T; Varas, C; Balana, L; Lopez, FN; Sanz, G; Ferrer, C; de Luna, AB; Caralps, JM; Dominguez, M; Monras, P; Rey, M
      Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries

      LANCET
    86. Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L
      Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease - Effect of grain fortification and beyond

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    87. Radford, MJ; Foody, JM
      How do observational studies expand the evidence base for therapy?

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    88. Robins, SJ; Collins, D; Wittes, JT; Papademetriou, V; Deedwania, PC; Schaefer, EJ; McNamara, JR; Kashyap, ML; Hershman, JM; Wexler, LF; Rubins, HB
      Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    89. Stanek, G
      Chlamydia pneumoniae - aetiologic agent of what?

      WIENER KLINISCHE WOCHENSCHRIFT
    90. Jonsson, N; Asplund, K
      Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study

      STROKE
    91. Hart, RG; Halperin, JL
      Atrial fibrillation and stroke - Concepts and controversies

      STROKE
    92. Lalouschek, W; Lang, W; Mullner, M
      Current strategies of secondary prevention after a cerebrovascular event -The Vienna stroke registry

      STROKE
    93. Blumel, JE; Campodonico, I
      Are transdermic estrogens cardioprotective?

      REVISTA MEDICA DE CHILE
    94. Spanheimer, RG
      Reducing cardiovascular risk in diabetes - Which factors to modify first?

      POSTGRADUATE MEDICINE
    95. Jolobe, OMP
      The real cost of aspirin

      POSTGRADUATE MEDICAL JOURNAL
    96. Crossen, K; Scott, RS; McGeoch, GRB; George, PM
      Implementation of evidence based cardiovascular risk treatments by generalpractitioners

      NEW ZEALAND MEDICAL JOURNAL
    97. Mohr, JP; Thompson, JLP; Lazar, RM; Levin, B; Sacco, RL; Furie, KL; Kistler, JP; Albers, GW; Pettigrew, LC; Adams, HP; Jackson, CM; Pullicino, P
      A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

      NEW ENGLAND JOURNAL OF MEDICINE
    98. Cuixart, CB; Pelaez, IM; Miralda, GP; Sole, AR; Castello, PC
      Therapeutic control and quality of life in coronary artery bypass surgery patients

      MEDICINA CLINICA
    99. Mudge, AM; Brockett, R; Foxcroft, KF; Denaro, CP
      Lipid-lowering therapy following major cardiac events: progress and deficits

      MEDICAL JOURNAL OF AUSTRALIA
    100. Bloom, JR; Stewart, SL; Koo, J; Hiatt, RA
      Cancer screening in public health clinics - The importance of clinic utilization

      MEDICAL CARE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 12:31:04